This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 834,513 Years Active: 2001
Title: Manuel Lopez: Innovator in Gene Therapy
Introduction
Manuel Lopez, a distinguished inventor based in Champigny sur Marne, France, has made significant contributions to the field of gene therapy. With one patent to his name, his innovative work focuses on the application of recombinant cells from the monocyte-macrophage cell line.
Latest Patents
Lopez's patent titled "Recombinant cells from the monocyte-macrophage cell line for gene therapy" showcases his groundbreaking approach. The patent describes cell compositions that utilize mononuclear phagocyte system cells, specifically targeting their application in cell therapy, including adoptive immunotherapy.
Career Highlights
Throughout his career, Manuel Lopez has been committed to advancing medical research and therapeutic techniques. His groundbreaking patent reflects his expertise in cellular biology and gene therapy, highlighting a significant achievement in the field.
Collaborations
In his innovative journey, Lopez has collaborated with notable colleagues such as Hedi Mohamed Haddada and Michel Perricaudet. Together, they work towards enhancing the understanding and application of gene therapy in clinical settings.
Conclusion
Manuel Lopez represents a new wave of inventors pushing the boundaries of medical science through innovation. His contributions to gene therapy mark him as a key figure in the field, promising potential advancements that could profoundly impact patient care and treatment efficacy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile